/Companies

Scale Medicine

New York, US · Founded 2023 · Delaware corporation · 1 known investors

Find your way into Scale Medicine

Sign up to see every warm intro you have to Scale Medicine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Scale Medicine team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Scale Medicine is an AI-native pharmaceutical company that applies artificial intelligence to improve the success rates of its clinical trials.

Founders & leadership

MR
Michael RetchinNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2023

▶$2MraisedDec 2023 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RetchinExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$2M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Scale Medicine do?
Scale Medicine is an AI-native pharmaceutical company that applies artificial intelligence to improve the success rates of its clinical trials.
Who are Scale Medicine's investors?
Scale Medicine's investors include Amino Collective.
How much funding has Scale Medicine raised?
Scale Medicine has disclosed $2M raised across 1 round.
Where is Scale Medicine headquartered?
Scale Medicine is headquartered in New York, US.